The Silicon Valley entrepreneur has turned his body into a living experiment in a bid to reframe longevity as a solvable ...

Huawei topped China’s smartphone market in Q2 2025 for the first time in four years, taking an 18.1% share despite a 3.4% drop in shipments, IDC said. National smartphone sales fell 4% amid weak ...

Sino Biopharmaceutical plans to acquire the remaining 95.09% of LaNova Medicines for up to USD 951 million, raising its stake to 100%. After accounting for LaNova’s estimated USD 450 million in cash, ...

Klook is exploring a US IPO that could raise USD 300–500 million, according to sources. Backed by SoftBank and Goldman Sachs, the travel booking platform turned profitable in 2023 and may file ...

ASML beat Q2 2025 estimates with EUR 7.7 billion in sales and EUR 5.5 billion in bookings but warned of potential flat growth in 2026 amid rising global uncertainty. The company also trimmed its 2025 ...

Ganfeng Lithium and Tianqi Lithium issued profit warnings for the first half of 2025, citing falling lithium prices and sector volatility. Ganfeng expects net losses of RMB 300–550 million, while ...

A single Saturday saw Taobao Shangou, Meituan, and JD.com log a combined 200 million orders, testing subsidy strength, ...

AI-powered therapy tools are emerging in the mental health space, but questions around empathy, safety, and readiness remain ...

Managed by Shanghai-based Xinguo Technology, HotMaxx’s “super warehouse” outlet in a Nanjing shopping mall has become its ...

Haagen-Dazs must reinvent itself in China or weigh an exit as it contends with fierce competition, narrow margins, and ...

Ten years after launching in a basement, the B2B robotics company is expanding across the logistics value chain.

Sino Biopharmaceutical plans to acquire the remaining 95.09% of LaNova Medicines for up to USD 951 million, raising its stake to 100%. After accounting for LaNova’s estimated USD 450 million in cash, ...